Transgender Healthcare

Transgender Healthcare

TransLucent Puberty Blocker (GnRH Analogues) Position Statement

Introduction TransLucent has carefully considered the factors contributing to the withdrawal of puberty blocker treatment, sometimes referred to as Gonadotropin-releasing hormone (GnRH) analogues for young trans people. Puberty blockers (GnRH analogues) work by mimicking a natural hormone, binding to receptors on the pituitary gland, which eventually pauses the production of…

Strategy

TransLucent Year End Operational Review

TransLucent advocates for the trans and non-binary community, which represents approximately 0.5% of the UK population, similar in size to the Jewish community. We are very aware of the toxicity of debates in the media and some parts of society concerning trans people’s human rights, and we are pleased that…

Briefing Notes

Human Rights

Human Rights

Healthcare

Editorial

Latest : TransLucent

View More ...
GIC Report into NHS trans healthcare service models

Introduction to GIC Report Adult trans healthcare via Gender Identity Clinics (GICs) has been in…

We will not be silent while human rights
are being eroded by bigotry and hatred.

Skip to content